During the past decade, Diseases of the Digestive System conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Diseases of the Digestive System" are "Crohn's Disease" (3 trials). Many other conditions were trialed in "Diseases of the Digestive System" in a lesser frequency.

Most popular intervention types in "Diseases of the Digestive System" are "Biological" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Adalimumab (D2E7)" (1 trials), "Adalimumab 40 mg eow or ew" (1 trials), "DB adalimumab 40 mg eow" (1 trials), "DB adalimumab 40 mg ew" (1 trials) and "Double-blind (DB) adalimumab placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Diseases of the Digestive System" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Diseases of the Digestive System". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Diseases of the Digestive System, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Diseases of the Digestive System, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".